DNTH
Dianthus Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$108.10
+0.23%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3794.11x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.16x
- Price / sales
- 3175.69x
- Price / cash flow
- -38.92x
Enterprise value
- Enterprise value
- $5.2B
- EV / sales
- 2710.60x
- EV / EBITDA
- -174.89x
- EV / EBIT
- -23.69x
- Market cap
- $6.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026